A critical review of various high risk situations in which neuroleptics could be used and have been used in clinical practice is presented. These high risk situations include: women of child bearing age (pregnant women, lactating and/or nursing mothers), the two extremes of life (children and the elderly), patients with sexual dysfunction, patients with tardive dyskinesia, non-psychotic psychiatric patients, physically ill and suicidal patients. The extraordinary applications of these drugs, such as for rapid tranquilization and megadose regimens are examined. The author provides guidelines for the use of neuroleptics in these clinical situations.
References
1.
NurnbergH.G.Breast feeding and psychotropic drugs. Letter toed.Am J Psychiatry1981; 138(1): 120–1.
2.
AnanthJ.Congenital malformations with psychopharmacologic agents.Compr Psychiatry1975; 16(5): 437–45.
3.
AydF.J.Jr.. Psychotropic drug therapy during pregnancy.International Drug Therapy Newsletter1976; 11: 512.
4.
AnanthJ.Side effects in the neonate from psychotropic agents excreted through breast feeding.Am J Psychiatry1978; 135: 801–5.
5.
NurnbergH.G.Treatment of mania in the last six months of pregnancy.Hosp Community Psychiatry1980; 31: 122–6.
6.
KopelmanA.E., McCellarF.W., HeggenessL.Limb malformations following maternal use of haloperidol.JAMA1975; 231(1): 62–4.
StewartR.B.V., KarasB., SpringerP.K.Haloperidol excretion in human milk.Am J Psychiatry1980; 137: 840–50.
9.
WhalleyL.J., BlainP.G., PrimeJ.K.Haloperidol secreted in breast milk.Br Med J1981; 282: 1746–1947.
10.
LundborgP., EngleJ.Learning deficits and selective biochemical brain changes in 4-week-old offspring of nursing rat mothers treated with neuroleptics. In: SedvallG., ed. Antipsychotic drugs, pharmacodynamics and pharmacokinetics.Oxford: Pergamon Press, 1975: 261–9.
11.
Van PraagH.M.Psychotropic drugs, a guide for the practitioner.New York: Brunner/Mazel, 1978.
12.
WerryJ.S.The use of psychotropic drugs in children.J Am Acad Child Psychiatry1977; 16(1–4): 446–8.
13.
WhiteJ.H.Psychopharmacology in childhood: current status and future prospectives.Psychiatric Clinics of North America1977; 3(3): 443–53.
14.
SerranoA.C.Haloperidol - its use in children.J Clin Psychiatry1981; 42(4): 154–6.
15.
HurwitzN.Predisposing factors in adverse reactions to drugs.Br Med J1969; ii: 536–40.
16.
SalzmanC.A primer on geriatric psychopharmacology.Am J Psychiatry1982; 139(1): 67–74.
17.
FreyhanF.A.Loss of ejaculation during mellaril.Am J Psychiatry1961; 118: 171–2.
18.
BlairJ.H., SimpsonG.M.Effect of antipsychotic drugs on reproductive functions.Dis Nerv Syst1966; 27: 645–7.
19.
KotinJ., WilbertD.E., VerburgD., SoldingerS.M.Thioridazine and sexual dysfunction.Am J Psychiatry1976; 133(1): 82–5.
20.
JeffriesJ.J.Piperacetazine-induced failure to ejaculate. Letter to ed.Can Psychiatr Assoc J1974; 19(3): 322–3.
21.
StoryH.L.Sexual dysfunction resulting from drug side effects.J Sex Res1974; 10: 132–49.
22.
SegravesR.T.Pharmacological agents causing sexual dysfunctions.J Sex Marital Ther1977; 3: 3.
23.
OsborneM.P.Penile parkinsonism.Post Graduate Medical Journal1974; 50: 523–4.
24.
SinghJ.Therapeutic use of thioridazine in premature ejaculation.Am J Psychiatry1963; 119: 891.
GardosG., ColeJ.O.Overview public health issues in tardive dyskinesia.Am J Psychiatry1980; 137(7): 776–81.
28.
CraneG.E.The prevention of tardive dyskinesis.Am J Psychiatry1977; 134(7): 756–8.
29.
GualtieriC.T.Pharmacotherapy of autistic and mentally retarded children: topics in autism and mental retardation.Audio Digest Psychiatry Cassette1982; 11(4).
30.
Task force on late neurological effects of antipsychotic drugs: tardive dyskinesia: summary of a task force report of the American Psychiatric Association.Am J Psychiatry1980; 137(10): 1163–72.
31.
SwettC.Jr.. Adverse reactions to chlorpromazine in medical patients. A report from the Boston collaborative drug surveillance program. Boston University Medical Centre. Current Therapeutic Research, Vol. 18, No. 1, Section 2.
32.
SwettC.Jr.. Outpatient phenothiazine use and bone marrow depression.Arch Gen Psychiatry1975; 32: 1416–8.
33.
KrembergM.R.Sudden death of a patient taking phenothiazine.Psychiatric Annals1978; 8(7): 371–3.
34.
ModestinJ., KrapfR., BokerW.A fatality during haloperidol treatment, mechanism of sudden death.Am J Psychiatry1981; 138(12): 1616–7.
35.
PeeleR., Von LoetzenI.S.Phenothiazine deaths: a critical review.Am J Psychiatry1973; 130: 306–9.
36.
HollisterL.E., KosekJ.C.Sudden death during treatment with phenothiazines derivatives.JAMA1965; 192: 1035–8.
37.
DonlonP.T., TupinJ.P.Successful suicides with thioridazine and mesoridazine: a result of probable cardiotoxicity.Arch Gen Psychiatry1977; 34: 955–7.
38.
NituradA., OproiuL.N.Suicidal risk in the treatment of out-patient schizophrenics with long acting neuroleptics.Agressologie1976; 19: c. 145–8.
39.
de AlarconR., CarneyJ.P.Severe depressive mood changes following slow-release intramuscular fluphenazine injection.Br Med J1977; 3(3): 564–7.
40.
AydF.J.Jr.. Guidelines for using short-acting intramuscular neuroleptics for rapid neuroleptization.International Drug Therapy Newsletter1977; 12(2, 3): 5–12.
41.
DonlonP.T., HopkinJ., TupinJ.P.Overview, efficacy and safety of rapid neuroleptization method with injectable haloperidol, behavioral considerations.Am J Psychiatry1979; 136: 273–8.
42.
ManP.L., ChenC.H.Rapid tranquilization of acutely psychotic patients with intramuscular haloperidol and chlorpromazine.Psychosomatics1973; 14: 59–63.
43.
StotskyB.A.Relative efficacy of parenthood haloperidol and thiothixene for the emergency treatment of acutely excited and agitated patients.Dis Nerv Syst1977; 38(12): 967–73.
44.
NebroskyR., JanowskyD., MunsonE., DepryD.Rapid treatment of acute psychotic symptoms with high dose and low dose haloperidol.Arch Gen Psychiatry1981; 38: 195–9.
45.
DanikJ.J., GoverdhamM.Haloperidol in the treatment of 120 psychotic patients.Am J Psychiatry1963; 120: 389–91.
46.
AndersonW.H., KuehuleJ.C.Diagnosis and early management of acute psychosis.N Engl J Med1981; 305(19): 1128–30.
47.
QuitkinF., RifkinA., KleinD.F.Very high dosage vs standard dosage fluphenazine in schizophrenia. A double blind study of non-chronic treatment-refractory patients.Arch Gen Psychiatry1975; 32: 1276–81.
48.
AydF.Large doses of chlorpromazine in the treatment of psychiatric patients.Dis Nerv Syst1955; 16: 146–9.
49.
AubreeJ.C., LaderM.H.High and very high dosage antipsychotics. A critical review.J Clin Psychiatry1980; 41: 10.
McClellindH.A., FarquharsonR.G., LeyburnP., FurnessJ.A., SchiffA.A.Very high dose fluphenazine decanoate. A controlled trial in chronic schizophrenia.Arch Gen Psychiatry1976; 33: 1435–9.
55.
GardosG., ColeJ.O.The importance of dosage in antipsychotic drug administration. A review of dose-response studies.Psychopharmacologia (Berlin)1973; 29: 221–30.
56.
ItilT., SaletuB., HsuW.. Clinical and quantitative EEG changes at different dosage levels of fluphenazine treatment.Acta Psychiatr Scand1971; 47: 440–51.
